151 related articles for article (PubMed ID: 7305440)
1. Polymorphonuclear granulocyte chemotaxis and chemotactic factor generation by concanavalin A-stimulated peripheral blood mononuclear cells in patients with psoriasis.
Csató M; Dobozy A; Hunyadi J; Kenderessy SA; Simon N
Arch Dermatol Res; 1981; 271(3):259-64. PubMed ID: 7305440
[TBL] [Abstract][Full Text] [Related]
2. Chemokinetic and chemotactic factors in psoriasis scale extracts.
Dahl MV; Lindroos WE; Nelson RD
J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.
Lundin A; Håkansson L; Michaëlsson G; Venge P
Arch Dermatol Res; 1987; 279(6):385-91. PubMed ID: 3674962
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the mobilities of granulocytes and the chemotactic factor production by human mononuclear cells (author's transl)].
Nakayama M
Hokkaido Igaku Zasshi; 1981 Mar; 56(2):217-31. PubMed ID: 7327510
[TBL] [Abstract][Full Text] [Related]
5. Chemotactic factor production by rat polymorphonuclear leukocytes: stimulation with opsonized zymosan particles and inhibition by dexamethasone.
Kurihara A; Ojima F; Tsurufuji S
Biochem Biophys Res Commun; 1984 Mar; 119(2):720-5. PubMed ID: 6712653
[TBL] [Abstract][Full Text] [Related]
6. Stimulus-dependent increased generation of oxygen intermediates in monocytes and polymorphonuclear leukocytes in psoriasis.
Schopf RE; Straussfeld E
J Invest Dermatol; 1985 Jan; 84(1):73-6. PubMed ID: 3965581
[TBL] [Abstract][Full Text] [Related]
7. Activation of chemotactic factors in serum and wound fluid by dextranomer.
Oredsson SU; Gottrup F; Beckmann A; Hohn DC
Surgery; 1983 Sep; 94(3):453-7. PubMed ID: 6193593
[TBL] [Abstract][Full Text] [Related]
8. Mononuclear cell versus monocyte chemotaxis in psoriasis.
Tosca A; Hatzis J; Panteleos D; Varelzidis A
J Dermatol; 1985 Jun; 12(3):226-31. PubMed ID: 3908525
[No Abstract] [Full Text] [Related]
9. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
[TBL] [Abstract][Full Text] [Related]
10. Polymorphonuclear leukocyte function in psoriasis: chemotaxis, chemokinesis, beta-adrenergic receptors, and proteolytic enzymes of polymorphonuclear leukocytes in the peripheral blood from psoriatic patients.
Fräki JE; Jakoi L; Davies AO; Lefkowitz RJ; Snyderman R; Lazarus GS
J Invest Dermatol; 1983 Sep; 81(3):254-7. PubMed ID: 6309987
[TBL] [Abstract][Full Text] [Related]
11. Polymorphonuclear leukocyte random migration and chemotaxis in psoriatic and healthy adult smokers and non-smokers.
Sonnex TS; Carrington P; Norris P; Greaves MW
Br J Dermatol; 1988 Nov; 119(5):653-9. PubMed ID: 3207619
[TBL] [Abstract][Full Text] [Related]
12. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
Preissner WC; Schröder JM; Christophers E
Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil chemotaxis in psoriasis before and after PUVA therapy.
Guillot B; Guilhou JJ; Vendrel JP; Meynadier J
Arch Dermatol Res; 1983; 275(1):19-22. PubMed ID: 6847241
[TBL] [Abstract][Full Text] [Related]
14. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
Kawohl G; Szperalski B; Schröder JM; Christophers E
Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
[TBL] [Abstract][Full Text] [Related]
15. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
Ternowitz T
J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
[TBL] [Abstract][Full Text] [Related]
16. Soluble Pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients.
Bunse T; Mahrle G
Acta Derm Venereol; 1996 Jan; 76(1):10-2. PubMed ID: 8721481
[TBL] [Abstract][Full Text] [Related]
17. Polymorphonuclear leukocyte function in psoriasis vulgaris.
Pease CT; Fennell M; Staughton RC; Brewerton DA
Br J Dermatol; 1987 Aug; 117(2):161-7. PubMed ID: 3651338
[TBL] [Abstract][Full Text] [Related]
18. [Changes in the chemoluminescence behavior of micro- and macrophages in psoriasis: more than just an epiphenomenon?].
Schopf RE; Straussfeld E; Morsches B
Z Hautkr; 1985 May; 60(10):797-8, 801-2, 807. PubMed ID: 4013455
[TBL] [Abstract][Full Text] [Related]
19. Polymorphonuclear leukocytes in psoriasis.
Glinski W; Mansbridge J
Cutis; 1985 May; 35(5):441-2. PubMed ID: 4006509
[No Abstract] [Full Text] [Related]
20. Normal chemotactic migration of polymorphonuclear leukocytes stimulated with mononuclear-derived chemotactic factor in ulcerative colitis.
Hermanowicz A; Nawarska Z
Int Arch Allergy Appl Immunol; 1986; 81(1):63-8. PubMed ID: 3744579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
